The finding that STAT3 activation inhibits wtp53 is not surprising, as STAT3 is a pro-oncogenic molecule while wtp53 acts as a tumor suppressor molecule whose function is incompatible with cancer development. The gene discussed is STAT3; the disease is cancer.